NEW YORK, Feb. 3 (GenomeWeb News) - Shares in Accelr8 were up 7.95 percent, or $.21, at $2.85 in late-afternoon trading after the company said it won a US patent for its OptiChem surface chemistry.
The stock shot up to $3.35 in early-morning trade before settling down to $2.85 in unusually heavy volume.